Search Results 1491-1500 of 25224 for oral

  1. Jaw surgery - Care at Mayo Clinic

    Mayo Clinic oral, jaw and face surgeons (maxillofacial surgeons) and orthodontists have vast experience in treating complex jaw conditions. They have ...

  2. Drugs and Supplements that Start with D - Mayo Clinic

    Da · Dabigatran (oral route) · Dabrafenib (oral route) · Dacarbazine. Also known as. Dacarbazine (intravenous route, injection route) · Dacarbazine (intravenous ...

  3. Continuation Study With Budesonide Oral Suspension (BOS) for Adolescent and Adult Subjects With Eosinophilic Esophagitis (EoE) - Mayo Clinic

    This is a continuation study of Budesonide Oral Suspension (BOS) in adults and adolescents with Eosinophilic Esophagitis (EoE) who have completed participation ...

  4. Cavities and tooth decay - Diagnosis and treatment - Mayo Clinic

    Bring in any mouthguards or oral appliances that you wear. Questions to ask your dentist. Basic questions to ask your dentist may include: Do I have a ...

  5. Drugs and Supplements that Start with D - Mayo Clinic

    Da · Dabigatran (oral route) · Dabrafenib (oral route) · Dacarbazine. Also known as. Dacarbazine (intravenous route, injection route) · Dacarbazine (intravenous ...

  6. Clinical Study of Oral cMET Inhibitor INC280 in Adult Patients With EGFR Wild-type Advanced Non-small Cell Lung Cancer

    A phase II study to evaluate antitumor activity of oral cMET inhibitor INC280 in adult patients with EGFR wild-type, advanced non-small cell lung cancer (NSCLC) ...

  7. Drugs and Supplements that Start with T - Mayo Clinic

    Tabloid. Also known as. Thioguanine (oral route) · Tabrecta. Also known as. Capmatinib (oral route) · Tachosil. Also known as. Fibrinogen and thrombin, human ( ...

  8. Oral N-acetylcysteine for Retinitis Pigmentosa - Mayo Clinic

    The purpose of this study is to evaluate the effectiveness and safety of oral N-acetylcysteine (NAC) in patients with retinitis pigmentosa (RP). Participation ...

  9. A Phase 1-2 Dose-Escalation and Cohort-Expansion Study of Oral eFT508 in Subjects With Hematological Malignancies - Mayo Clinic

    The study will evaluate oral daily administration of eFT508. Treatment and study subject evaluation will be performed in 21-day cycles. Participation ...

  10. Once-daily Oral VT-464 in Patients With Castration-Resistant Prostate Cancer Progressing on Enzalutamide or Abiraterone. - Mayo Clinic

    Once-daily Oral VT-464 in Patients With Castration-Resistant Prostate Cancer Progressing on Enzalutamide or Abiraterone. · More about research at Mayo Clinic.